West Pharma (WST) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
West Announces First Quarter 2015 Results
April 30, 2015 7:01 AM EDTEXTON, PA -- (Marketwired) -- 04/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2015 and updated financial guidance for the full year 2015.
Highlights
Improved sales mix fuels wider gross margin and 21.6% growth in operating profit First-quarter diluted EPS rose 18.4% to $0.45 per share Reported sales declined 3.1% due to currency 6.5% growth in net sales at constant currency(1) Maintains 2015 constant currency sales growth estimate in the range of 6% to 8% Reported sales expected to be 1% to 2% lower Narrows... More